{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:35Z","timestamp":1792839635713,"version":"4.5.0"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1400,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Primary sclerosing cholangitis (PSC) is a chronic fibroinflammatory syndrome involving the biliary tract, often accompanied by inflammatory bowel disease (IBD). This syndrome is a prototype disease linking chronic inflammation to carcinogenesis. Indeed, PSC is associated with an increased risk of cholangiocarcinoma (CCA), gallbladder cancer, hepatocellular carcinoma (HCC), and colorectal cancer. Herein, we review the risk for these malignancies in PSC and discuss rational cancer surveillance strategies for these patients. Where evidence is limited, we suggest a pragmatic approach. In this regard, we recommend interval screening for CCA with noninvasive imaging modalities and serum carbohydrate antigen 19-9 determinations annually. These imaging studies also serve to screen for gallbladder cancer and HCC. Screening for colorectal cancer is more firmly established in PSC patients with IBD and includes colonoscopy at the time of PSC diagnosis and, thereafter, at 1-2-year intervals. We also highlight areas where more information is required, such as management of biliary tract dysplasia and cancer chemoprevention in PSC. (Hepatology 2011)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.24570","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T13:49:21Z","timestamp":1311688161000},"page":"1842-1852","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":252,"title":["Cancer surveillance in patients with primary sclerosing cholangitis"],"prefix":"10.1097","volume":"54","author":[{"given":"Nataliya","family":"Razumilava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20241202","doi-asserted-by":"crossref","first-page":"13641369","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"R2-35-20241202","first-page":"99103","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"R3-35-20241202","doi-asserted-by":"crossref","first-page":"10421049","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a populationbased analysis.","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R4-35-20241202","doi-asserted-by":"crossref","first-page":"19291930","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom.","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"R5-35-20241202","doi-asserted-by":"crossref","first-page":"787791","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol"},{"key":"R6-35-20241202","doi-asserted-by":"crossref","first-page":"908913","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore.","volume":"17","author":"Ang","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R7-35-20241202","doi-asserted-by":"crossref","first-page":"571577","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden.","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"R8-35-20241202","doi-asserted-by":"crossref","first-page":"321327","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"R9-35-20241202","doi-asserted-by":"crossref","first-page":"523526","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R10-35-20241202","doi-asserted-by":"crossref","first-page":"512516","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"key":"R11-35-20241202","doi-asserted-by":"crossref","first-page":"660678","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis.","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"R13-35-20241202","doi-asserted-by":"crossref","first-page":"843857","DOI":"10.1016\/j.rcl.2010.06.005","article-title":"The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening.","volume":"48","author":"Kopans","year":"2010","journal-title":"Radiol Clin North Am"},{"key":"R14-35-20241202","doi-asserted-by":"crossref","first-page":"192199","DOI":"10.7326\/0003-4819-149-3-200808050-00009","article-title":"Benefits and harms of prostatespecific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.","volume":"149","author":"Lin","year":"2008","journal-title":"Ann Intern Med"},{"key":"R15-35-20241202","first-page":"18691875","article-title":"Improved survival with promary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients.","volume":"92","author":"Helzberg","year":"1887","journal-title":"Gastroenterology"},{"key":"R16-35-20241202","doi-asserted-by":"crossref","first-page":"17101717","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis.","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"R17-35-20241202","doi-asserted-by":"crossref","first-page":"10421045","DOI":"10.3109\/00365529709011222","article-title":"Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A populationbased study.","volume":"32","author":"Kornfeld","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R18-35-20241202","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1055\/s-2008-1040419","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis.","volume":"11","author":"Rosen","year":"1991","journal-title":"Semin Liver Dis"},{"key":"R19-35-20241202","doi-asserted-by":"crossref","first-page":"610615","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"R20-35-20241202","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"R21-35-20241202","first-page":"14041408","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"key":"R22-35-20241202","doi-asserted-by":"crossref","first-page":"311316","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a casecontrol study.","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"R23-35-20241202","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter casecontrol study.","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"R24-35-20241202","doi-asserted-by":"crossref","first-page":"620626","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a casecontrol study.","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"R25-35-20241202","doi-asserted-by":"crossref","first-page":"12051211","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"R26-35-20241202","doi-asserted-by":"crossref","first-page":"158164","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis.","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"R27-35-20241202","doi-asserted-by":"crossref","first-page":"11061117","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"R29-35-20241202","doi-asserted-by":"crossref","first-page":"139154","DOI":"10.1055\/s-2004-828891","article-title":"Serum and bile markers for cholangiocarcinoma.","volume":"24","author":"Nehls","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R30-35-20241202","doi-asserted-by":"crossref","first-page":"10641072","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures.","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"key":"R31-35-20241202","first-page":"21802186","article-title":"A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.","volume":"136","author":"Fritcher","year":"2009","journal-title":"Gastroenterology"},{"key":"R32-35-20241202","doi-asserted-by":"crossref","first-page":"16751681","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R33-35-20241202","doi-asserted-by":"crossref","first-page":"174180","DOI":"10.1002\/hep.23277","article-title":"Longterm outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"R34-35-20241202","doi-asserted-by":"crossref","first-page":"855860","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R35-35-20241202","doi-asserted-by":"crossref","first-page":"907913","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasiadysplasiacarcinoma sequence.","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R36-35-20241202","doi-asserted-by":"crossref","first-page":"265281","DOI":"10.1007\/s00534-002-0729-3","article-title":"Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.","volume":"10","author":"Nakanuma","year":"2003","journal-title":"J Hepatobil Pancreat Surg"},{"key":"R37-35-20241202","doi-asserted-by":"crossref","first-page":"542550","DOI":"10.1007\/s005340070002","article-title":"Precancerous lesions of intrahepatic cholangiocarcinoma.","volume":"7","author":"Shimonishi","year":"2000","journal-title":"J Hepatobil Pancreat Surg"},{"key":"R38-35-20241202","doi-asserted-by":"crossref","first-page":"360365","DOI":"10.1016\/S0168-8278(00)00034-9","article-title":"Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis.","volume":"34","author":"Fleming","year":"2001","journal-title":"J Hepatol"},{"key":"R39-35-20241202","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1046\/j.1365-2796.2001.00775.x","article-title":"Biliary dysplasia, cell proliferation, and nuclear DNAfragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.","volume":"249","author":"Bergquist","year":"2001","journal-title":"J Intern Med"},{"key":"R40-35-20241202","doi-asserted-by":"crossref","first-page":"21342138","DOI":"10.1016\/0016-5085(92)90343-W","article-title":"Papillary bile duct dysplasia in primary sclerosing cholangitis.","volume":"102","author":"Ludwig","year":"1992","journal-title":"Gastroenterology"},{"key":"R41-35-20241202","doi-asserted-by":"crossref","first-page":"349355","DOI":"10.1097\/00000478-200303000-00008","article-title":"The extrahepatic bile duct lesions in endstage primary sclerosing cholangitis.","volume":"27","author":"Katabi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R42-35-20241202","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in endstage primary sclerosing cholangitis, with and without cholangiocarcinoma.","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R43-35-20241202","doi-asserted-by":"crossref","first-page":"568574","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"R44-35-20241202","doi-asserted-by":"crossref","first-page":"18741887","DOI":"10.1007\/s11605-009-0935-2","article-title":"Preemptive surgery for premalignant foregut lesions.","volume":"13","author":"Sharma","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"R45-35-20241202","doi-asserted-by":"crossref","first-page":"692697","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma.","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"key":"R46-35-20241202","doi-asserted-by":"crossref","first-page":"11381142","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R47-35-20241202","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0168-8278(07)62274-0","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis.","volume":"46","author":"Said","year":"2007","journal-title":"J Hepatol"},{"key":"R49-35-20241202","first-page":"349364","article-title":"Epidemiology and molecular pathology of gallbladder cancer.","volume":"51","author":"LazcanoPonce","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"R51-35-20241202","doi-asserted-by":"crossref","first-page":"12711277","DOI":"10.1517\/14656566.5.6.1271","article-title":"Gallbladder cancer: current status.","volume":"5","author":"Malik","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"R53-35-20241202","first-page":"1925","article-title":"Comparison of surgically resected polypoid lesions of the gallbladder to their preoperative ultrasound characteristics.","volume":"13","author":"Zielinski","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R54-35-20241202","doi-asserted-by":"crossref","first-page":"414417","DOI":"10.1046\/j.1365-2168.2000.01363.x","article-title":"Surgical management of polypoid lesions of the gallbladder.","volume":"87","author":"Mainprize","year":"2000","journal-title":"Br J Surg"},{"key":"R55-35-20241202","doi-asserted-by":"crossref","first-page":"114117","DOI":"10.1016\/S0002-9610(97)00262-6","article-title":"Surgical indications for small polypoid lesions of the gallbladder.","volume":"175","author":"Shinkai","year":"1998","journal-title":"Am J Surg"},{"key":"R56-35-20241202","first-page":"97105","article-title":"Factors associated with malignancy in gallbladder polyps without gallbladder stone.","volume":"52","author":"Lee","year":"2008","journal-title":"Korean J Gastroenterol"},{"key":"R57-35-20241202","doi-asserted-by":"crossref","first-page":"689698","DOI":"10.1155\/2008\/824168","article-title":"Primary sclerosing cholangitis.","volume":"22","author":"Silveira","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"R58-35-20241202","doi-asserted-by":"crossref","first-page":"571574","DOI":"10.2214\/ajr.150.3.571","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis.","volume":"150","author":"Brandt","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"R59-35-20241202","doi-asserted-by":"crossref","first-page":"167176","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder.","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol"},{"key":"R60-35-20241202","doi-asserted-by":"crossref","first-page":"395399","DOI":"10.1097\/MOG.0b013e3282f5727a","article-title":"Gallbladder polyps in primary sclerosing cholangitis: not so benign.","volume":"24","author":"Karlsen","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"R61-35-20241202","doi-asserted-by":"crossref","first-page":"815822","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis: predictors and consequences of hepatobiliary malignancy.","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"R62-35-20241202","first-page":"19221929","article-title":"Simultaneous detection of synchronous colonic and biliary carcinoma by abdominal ultrasonography in two patients with ulcerative colitis.","volume":"49","author":"KlingenbergNoftz","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R63-35-20241202","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1111\/j.1432-2277.2004.00022.x","article-title":"Gallbladder cancer and liver transplantation.","volume":"18","author":"Schmitt","year":"2005","journal-title":"Transpl Int"},{"key":"R64-35-20241202","doi-asserted-by":"crossref","first-page":"827832","DOI":"10.1245\/s10434-006-9224-4","article-title":"Incidence pattern and survival for gallbladder cancer over three decadesan analysis of 10,301 patients.","volume":"14","author":"Kiran","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R66-35-20241202","first-page":"3236","article-title":"Analysis of prognostic factors after curative resection for gallbladder carcinoma.","volume":"48","author":"Park","year":"2006","journal-title":"Korean J Gastroenterol"},{"key":"R67-35-20241202","first-page":"14931497","article-title":"Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates.","volume":"70","author":"Henson","year":"1992","journal-title":"Cancer"},{"key":"R68-35-20241202","doi-asserted-by":"crossref","first-page":"598605","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis.","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"R69-35-20241202","first-page":"237267","article-title":"collaborating on behalf of the European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases.","volume":"51","author":"Beuers","year":"2009","journal-title":"J Hepatol"},{"key":"R70-35-20241202","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11605-008-0725-2","article-title":"Comparison of surgically resected polypoid lesions of the gallbladder to their preoperative ultrasound characteristics.","volume":"13","author":"Zielinski","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"R71-35-20241202","doi-asserted-by":"crossref","first-page":"355357","DOI":"10.1111\/j.1445-2197.2007.04059.x","article-title":"Gall bladder polyps in sclerosing cholangitis: does the 1cm rule apply?","volume":"77","author":"Leung","year":"2007","journal-title":"ANZ J Surg"},{"key":"R72-35-20241202","doi-asserted-by":"crossref","first-page":"704706","DOI":"10.1007\/s00535-002-1126-z","article-title":"Early gallbladder carcinoma associated with primary sclerosing cholangitis and ulcerative colitis.","volume":"38","author":"Yamamoto","year":"2003","journal-title":"J Gastroenterol"},{"key":"R73-35-20241202","first-page":"135","article-title":"Management of hepatocellular carcinoma: an update.","volume":"000","author":"Bruix","year":"2010","journal-title":"Hepatology"},{"key":"R74-35-20241202","doi-asserted-by":"crossref","first-page":"723728","DOI":"10.1016\/j.jhep.2010.07.025","article-title":"Optimization of imaging diagnosis of 12 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.","volume":"54","author":"Khalili","year":"2011","journal-title":"J Hepatol"},{"key":"R75-35-20241202","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1136\/gut.2004.046615","article-title":"PSCIBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"R76-35-20241202","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a metaanalysis.","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"R77-35-20241202","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"R78-35-20241202","doi-asserted-by":"crossref","first-page":"12281233","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A populationbased study.","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"R79-35-20241202","doi-asserted-by":"crossref","first-page":"706711","DOI":"10.3109\/00365529708996522","article-title":"Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"32","author":"Leidenius","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R80-35-20241202","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis.","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"R81-35-20241202","first-page":"296300","article-title":"Pediatric PSCIBD: a descriptive report of associated inflammatory bowel disease among pediatric patients with psc.","volume":"33","author":"Faubion","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R82-35-20241202","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1080\/00365520801977568","article-title":"Relationship between clinical parameters and the colitiscolorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.","volume":"44","author":"Brackmann","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"R83-35-20241202","doi-asserted-by":"crossref","first-page":"854862","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a casecontrol study.","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R84-35-20241202","doi-asserted-by":"crossref","first-page":"451456","DOI":"10.1007\/BF02258391","article-title":"Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study.","volume":"40","author":"Lundqvist","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"R85-35-20241202","doi-asserted-by":"crossref","first-page":"13011305","DOI":"10.1007\/BF02049156","article-title":"Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.","volume":"38","author":"Broome","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"R86-35-20241202","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.cgh.2010.09.020","article-title":"Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis.","volume":"9","author":"Thackeray","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R87-35-20241202","doi-asserted-by":"crossref","first-page":"313317","DOI":"10.1016\/j.jhep.2010.02.030","article-title":"In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.","volume":"53","author":"Rudolph","year":"2010","journal-title":"J Hepatol"},{"key":"R88-35-20241202","doi-asserted-by":"crossref","first-page":"477480","DOI":"10.1002\/hep.1840110320","article-title":"Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis.","volume":"11","author":"Higashi","year":"1990","journal-title":"Hepatology"},{"key":"R89-35-20241202","doi-asserted-by":"crossref","first-page":"685690","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"key":"R90-35-20241202","first-page":"7174","article-title":"Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?","volume":"343","author":"Bernstein","year":"1994","journal-title":"Lancet"},{"key":"R91-35-20241202","doi-asserted-by":"crossref","first-page":"12991310","DOI":"10.1016\/j.gie.2008.08.042","article-title":"Medical decision analysis for the management of unifocal, flat, lowgrade dysplasia in ulcerative colitis.","volume":"69","author":"Nguyen","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"R92-35-20241202","doi-asserted-by":"crossref","first-page":"13521356","DOI":"10.1002\/ibd.21184","article-title":"Outcome after surveillance of lowgrade and indefinite dysplasia in patients with ulcerative colitis.","volume":"16","author":"Pekow","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R93-35-20241202","doi-asserted-by":"crossref","first-page":"288302","DOI":"10.1097\/00054725-199712000-00007","article-title":"Interactions between chronic liver disease and inflammatory bowel disease.","volume":"3","author":"Loftus","year":"1997","journal-title":"Inflamm Bowel Dis"},{"key":"R94-35-20241202","doi-asserted-by":"crossref","first-page":"175178","DOI":"10.1007\/BF02047543","article-title":"Colectomy in patients with inflammatory bowel disease and primary sclerosing cholangitis.","volume":"37","author":"Post","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"R95-35-20241202","doi-asserted-by":"crossref","first-page":"96103","DOI":"10.1016\/j.jamcollsurg.2008.09.006","article-title":"Nationwide volume and mortality after elective surgery in cirrhotic patients.","volume":"208","author":"Csikesz","year":"2009","journal-title":"J Am Coll Surg"},{"key":"R98-35-20241202","doi-asserted-by":"crossref","first-page":"10361042","DOI":"10.1016\/0016-5085(88)90180-1","article-title":"Prospective trial of penicillamine in primary sclerosing cholangitis.","volume":"95","author":"LaRusso","year":"1988","journal-title":"Gastroenterology"},{"key":"R99-35-20241202","doi-asserted-by":"crossref","first-page":"494499","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A doubleblind controlled trial of oralpulse methotrexate therapy in the treatment of primary sclerosing cholangitis.","volume":"106","author":"Knox","year":"1994","journal-title":"Gastroenterology"},{"key":"R100-35-20241202","doi-asserted-by":"crossref","first-page":"11991203","DOI":"10.1016\/0016-5085(95)90220-1","article-title":"Colchicine treatment of primary sclerosing cholangitis.","volume":"108","author":"Olsson","year":"1995","journal-title":"Gastroenterology"},{"key":"R101-35-20241202","doi-asserted-by":"crossref","first-page":"691695","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing CholangitisUrsodeoxycholic Acid Study Group.","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"R102-35-20241202","doi-asserted-by":"crossref","first-page":"900907","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of highdose ursodeoxycholic acid in primary sclerosing cholangitis.","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"R103-35-20241202","doi-asserted-by":"crossref","first-page":"14641472","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"Highdose ursodeoxycholic acid in primary sclerosing cholangitis: a 5year multicenter, randomized, controlled study.","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"R104-35-20241202","doi-asserted-by":"crossref","first-page":"808814","DOI":"10.1002\/hep.23082","article-title":"Highdose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R106-35-20241202","doi-asserted-by":"crossref","first-page":"889893","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"R107-35-20241202","doi-asserted-by":"crossref","first-page":"8995","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"issue":"Suppl2","key":"R109-35-20241202","first-page":"A653","article-title":"Mesalamine reduces the rate of colorectal dysplasia in patients with inflammatory bowel disease and primary sclerosing cholangitis who are on ursodeoxycholic acid abstract.","volume":"130","author":"Smith","year":"2006","journal-title":"Gastroenterology"},{"key":"R110-35-20241202","doi-asserted-by":"crossref","first-page":"675712","DOI":"10.1016\/j.gtc.2006.07.003","article-title":"Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.","volume":"35","author":"Chan","year":"2006","journal-title":"Gastroenterol Clin North Am"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24570","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201111000-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:08:42Z","timestamp":1733155722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201111000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24570","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}